Milivojevic Vladimir, Milosavljevic Tomica
Clinic of Gastroenterology and Hepatology, Clinical Center of Serbia, School of Medicine, Belgrade University, Koste Todorovic N 2, Belgrade, Serbia.
School of Medicine, Belgrade University, Belgrade, Serbia.
Curr Treat Options Gastroenterol. 2020 Jan 28;18(1):148-157. doi: 10.1007/s11938-020-00277-z. Print 2020 Mar.
We reviewed the recent medical literature to show global burden of gastroduodenal disease, potential strategies, and further perspectives.
Gastrointestinal and liver diseases are growing health problems, and cause more than 8 million deaths per year worldwide; encompass a range of long-term health conditions, such as digestive cancers, gastroesophageal reflux disease, Helicobacter pylori infection, peptic ulcer disease, liver diseases, inflammatory bowel disease, coeliac disease, and functional gastrointestinal disorders. Scientific knowledge demonstrates that the noncommunicable disease burden can be greatly reduced if cost-effective preventive and curative actions, along with interventions for prevention and control of noncommunicable diseases already available, are implemented in an effective and balanced manner.
Future research will have to elaborate on simple methods for preselection of patients at high risk to allow their implementation in strategies and respect all demand of cost-effectiveness. Understanding trends in GI illnesses could be helpful to meet the needs of patients and decrease the disease burden.
我们回顾了近期医学文献,以展示全球胃十二指肠疾病负担、潜在策略及进一步展望。
胃肠和肝脏疾病对健康的影响日益严重,全球每年导致超过800万人死亡;涵盖一系列长期健康问题,如消化道癌症、胃食管反流病、幽门螺杆菌感染、消化性溃疡病、肝脏疾病、炎症性肠病、乳糜泻和功能性胃肠疾病。科学知识表明,如果以有效且平衡的方式实施具有成本效益的预防和治疗措施以及现有的非传染性疾病预防和控制干预措施,非传染性疾病负担可大幅降低。
未来研究需详细阐述针对高危患者进行预筛选的简单方法,以便将其应用于策略中,并满足所有成本效益要求。了解胃肠疾病趋势有助于满足患者需求并减轻疾病负担。